Log in to save to my catalogue

Clinical and molecular characterization of HER2amplified-pancreatic cancer

Clinical and molecular characterization of HER2amplified-pancreatic cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A534783507

Clinical and molecular characterization of HER2amplified-pancreatic cancer

Publication information

Publisher

BioMed Central Ltd

More information

Scope and Contents

Contents

Background Pancreatic cancer is one of the most lethal and molecularly diverse malignancies. Repurposing of therapeutics that target specific molecular mechanisms in different disease types offers potential for rapid improvements in outcome. Although HER2 amplification occurs in pancreatic cancer, it is inadequately characterized to exploit the pot...

Alternative Titles

Full title

Clinical and molecular characterization of HER2amplified-pancreatic cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A534783507

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A534783507

Other Identifiers

ISSN

1756-994X

E-ISSN

1756-994X

DOI

10.1186/gm482

How to access this item